AXGN

SEC source: 0000805928-21-000142 · wf-form4_162689841095311.xml · nonDerivative · entry 1

Billet Isabelle · CIK 0001756302 · Chief Strategy and BD Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,088

F1 · shares: This reflects the number of shares that became vested as of July 19, 2021 upon the attainment of certain performance criteria.

SEC source: 0000805928-21-000141 · wf-form4_162689838247457.xml · nonDerivative · entry 1

MARTINEZ MARIA D. · CIK 0001633672 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,504

F1 · shares: This reflects the number of shares that became vested as of July 19, 2021 upon the attainment of certain performance criteria.

SEC source: 0000805928-21-000140 · wf-form4_162689834317764.xml · nonDerivative · entry 1

Friedman Mark Louis · CIK 0001531023 · VP Regulatory Affairs & Policy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,945

F1 · shares: This reflects the number of shares that became vested as of July 19, 2021 upon the attainment of certain performance criteria.

SEC source: 0000899243-21-029207 · doc4.xml · derivative · entry 1

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,638

Underlying: Common Stock · 27,638 shares

Expires 2031-07-19

F1 · derivative.exercise_date: The shares subject to this option will vest in three equal installments on the annual anniversary of the grant date with the first vesting date occurring on July 19, 2022.

SEC source: 0000805928-21-000121 · wf-form4_162430665353712.xml · derivative · entry 3

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,250 shares

Expires 2028-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on December 27, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.

SEC source: 0000805928-21-000121 · wf-form4_162430665353712.xml · nonDerivative · entry 2

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,775

F1 · shares: Of the 8,781 reported shares, 8,477 shares were swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule 16b-3. Additionally, 304 shares of common stock were surrendered to satisfy the reporting person's tax withholding liability. In total, the reporting person received 469 additional shares of common stock.

SEC source: 0000805928-21-000121 · wf-form4_162430665353712.xml · nonDerivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,556

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Of the 8,781 reported shares, 8,477 shares were swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule 16b-3. Additionally, 304 shares of common stock were surrendered to satisfy the reporting person's tax withholding liability. In total, the reporting person received 469 additional shares of common stock.

SEC source: 0000805928-21-000119 · wf-form4_162318392442431.xml · nonDerivative · entry 1

MARTINEZ MARIA D. · CIK 0001633672 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,932

SEC source: 0000805928-21-000118 · wf-form4_162318390357941.xml · derivative · entry 2

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,000 shares

Expires 2021-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: All shares pursuant to the employee stock option will became vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter.

F1 · derivative.expiration_date: All shares pursuant to the employee stock option will became vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter.

SEC source: 0000805928-21-000118 · wf-form4_162318390357941.xml · nonDerivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000113 · wf-form4_162275490582369.xml · derivative · entry 4

Gold Mark Stephen · CIK 0001531332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,036

Underlying: Common Stock · 3,036 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F4 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F4 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000113 · wf-form4_162275490582369.xml · derivative · entry 3

Gold Mark Stephen · CIK 0001531332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires 2031-06-01

F4 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000113 · wf-form4_162275490582369.xml · derivative · entry 2

Gold Mark Stephen · CIK 0001531332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,173 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3 · derivative.exercise_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

F3 · derivative.expiration_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

SEC source: 0000805928-21-000113 · wf-form4_162275490582369.xml · nonDerivative · entry 1

Gold Mark Stephen · CIK 0001531332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,439

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The shares of common stock for Dr. Gold include 159,575 shares held jointly by Dr. Gold and his wife, indirect ownership of 22,000 shares held by Dr. Gold's spouse in revocable trusts, and indirect ownership of 92,000 shares held by MJSK, Ltd., a decedent investment trust.

SEC source: 0000805928-21-000112 · wf-form4_162275486446760.xml · derivative · entry 2

THOMAS PAUL · CIK 0001166776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,036

Underlying: Common Stock · 3,036 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F1 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000112 · wf-form4_162275486446760.xml · derivative · entry 1

THOMAS PAUL · CIK 0001166776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires 2031-06-01

F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000111 · wf-form4_162275483321636.xml · derivative · entry 4

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,036

Underlying: Common Stock · 3,036 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F3 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000111 · wf-form4_162275483321636.xml · derivative · entry 3

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires 2031-06-01

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000111 · wf-form4_162275483321636.xml · derivative · entry 2

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,173 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2 · derivative.exercise_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

F2 · derivative.expiration_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

SEC source: 0000805928-21-000111 · wf-form4_162275483321636.xml · nonDerivative · entry 1

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,097

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000110 · wf-form4_162275480526647.xml · derivative · entry 2

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,036

Underlying: Common Stock · 3,036 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F1 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000110 · wf-form4_162275480526647.xml · derivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires 2031-06-01

F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000109 · wf-form4_162275477699109.xml · derivative · entry 4

Blackford Quentin S. · CIK 0001612451 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,036

Underlying: Common Stock · 3,036 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F3 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000109 · wf-form4_162275477699109.xml · derivative · entry 3

Blackford Quentin S. · CIK 0001612451 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires 2031-06-01

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000109 · wf-form4_162275477699109.xml · derivative · entry 2

Blackford Quentin S. · CIK 0001612451 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,173 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2 · derivative.exercise_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

F2 · derivative.expiration_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

SEC source: 0000805928-21-000109 · wf-form4_162275477699109.xml · nonDerivative · entry 1

Blackford Quentin S. · CIK 0001612451 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,299

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000108 · wf-form4_162275473035646.xml · derivative · entry 4

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,036

Underlying: Common Stock · 3,036 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F3 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000108 · wf-form4_162275473035646.xml · derivative · entry 3

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires 2031-06-01

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000108 · wf-form4_162275473035646.xml · derivative · entry 2

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,173 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2 · derivative.exercise_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

F2 · derivative.expiration_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

SEC source: 0000805928-21-000108 · wf-form4_162275473035646.xml · nonDerivative · entry 1

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000107 · wf-form4_162275467679419.xml · derivative · entry 4

Levine Alan M · CIK 0001766833 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,036

Underlying: Common Stock · 3,036 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F3 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000107 · wf-form4_162275467679419.xml · derivative · entry 3

Levine Alan M · CIK 0001766833 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires 2031-06-01

F3 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

SEC source: 0000805928-21-000107 · wf-form4_162275467679419.xml · derivative · entry 2

Levine Alan M · CIK 0001766833 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,173 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2 · derivative.exercise_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

F2 · derivative.expiration_date: This reflects the number of restricted stock units that became vested as of June 1, 2021.

SEC source: 0000805928-21-000107 · wf-form4_162275467679419.xml · nonDerivative · entry 1

Levine Alan M · CIK 0001766833 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · derivative · entry 10

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2026-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · derivative · entry 9

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2023-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016. The option vested in two equal installments beginning on September 30, 2016, and became fully vested on December 31, 2016.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · derivative · entry 8

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2023-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on May 26, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on May 26, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · derivative · entry 7

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,000 shares

Expires 2022-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2019 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2016 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · derivative · entry 6

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,954 shares

Expires 2021-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · nonDerivative · entry 5

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · nonDerivative · entry 4

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · nonDerivative · entry 3

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · nonDerivative · entry 2

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000099 · wf-form4_162223233198745.xml · nonDerivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-21-000096 · wf-form4_162162845853460.xml · derivative · entry 4

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2022-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016 (1 year from the option grant date) based upon a vesting schedule whereby 25% of the total shares vested at the end of each fiscal quarter.

SEC source: 0000805928-21-000096 · wf-form4_162162845853460.xml · derivative · entry 3

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-08-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on August 26, 2017 (2 years from the option grant date) based upon a vesting schedule whereby 12.5% of total shares vested at the end of each fiscal quarter.

SEC source: 0000805928-21-000096 · wf-form4_162162845853460.xml · nonDerivative · entry 2

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,591

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Reporting Person has elected to exercise and hold the shares at this time.

SEC source: 0000805928-21-000096 · wf-form4_162162845853460.xml · nonDerivative · entry 1

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,591

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Reporting Person has elected to exercise and hold the shares at this time.

SEC source: 0000805928-21-000115 · wf-form4a_162310109457355.xml · derivative · entry 4

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2022-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016 (1 year from the option grant date) based upon a vesting schedule whereby 25% of the total shares vested at the end of each fiscal quarter.

SEC source: 0000805928-21-000115 · wf-form4a_162310109457355.xml · derivative · entry 3

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-08-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option became fully vested on August 26, 2017 (2 years from the option grant date) based upon a vesting schedule whereby 12.5% of total shares vested at the end of each fiscal quarter.